The Consultant & Investment Group (AMM:CICO) Research & Development: JOD0.00 Mil (TTM As of Mar. 2026)


AMM:CICO The Consultant & Investment Group AMM:CICO
77 GF Score
Price JOD1.78
GF Value JOD2.20
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is The Consultant & Investment Group Research & Development?

The Consultant & Investment Group AMM:CICO 77 Research & Development is JOD0.00 Mil as of Mar. 2026. GuruFocus rates AMM:CICO with a GF Score™ of 77/100 and a GF Value™ of JOD2.20 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. The Consultant & Investment Group's Research & Development for the three months ended in Mar. 2026 was JOD0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was JOD0.00 Mil.

The Consultant & Investment Group  (AMM:CICO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

The Consultant & Investment Group Research & Development Related Terms

The Consultant & Investment Group Research & Development Historical Data

* Premium members only.

The historical data trend for The Consultant & Investment Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Consultant & Investment Group Research & Development Chart

The Consultant & Investment Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

The Consultant & Investment Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
AMM:CICO
77GF Score
The Consultant & Investment Group AMM:CICO
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Consultant & Investment Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was JOD0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of JOD0.00 Mil mean?
The Consultant & Investment Group (AMM:CICO) has a Research & Development of JOD0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on The Consultant & Investment Group and its competitors.
Is The Consultant & Investment Group's Research & Development too high?
The Consultant & Investment Group's current Research & Development is JOD0.00 Mil. Overall, The Consultant & Investment Group has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Consultant & Investment Group's Research & Development compare to HCA and THC?
The Consultant & Investment Group's Research & Development of JOD0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on The Consultant & Investment Group and its competitors. The Consultant & Investment Group's current Research & Development is JOD0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Consultant & Investment Group stock overvalued right now?
Based on GuruFocus' analysis, The Consultant & Investment Group (AMM:CICO) is currently considered Modestly Undervalued. The stock's GF Value™ is JOD2.20, compared to a current price of JOD1.78 — trading 19.1% below its estimated fair value. The current Research & Development is JOD0.00 Mil. The Consultant & Investment Group's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For The Consultant & Investment Group (AMM:CICO), the current Research & Development is JOD0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Consultant & Investment Group (AMM:CICO) Overvalued in 2026?

Based on GuruFocus' analysis, The Consultant & Investment Group stock appears to be undervalued. The current stock price of JOD1.78 is trading 19.1% below its estimated GF Value™ of JOD2.20. GuruFocus considers The Consultant & Investment Group to be Modestly Undervalued.

Key valuation signals for AMM:CICO:

  • Research & Development: JOD0.00 Mil
  • GF Value™: JOD2.20 vs. price of JOD1.78 (19.1% below fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the AMM:CICO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Consultant & Investment Group Business Description

Address 44 Al Kindi Street, Wadi Saqrah, P.O. Box 840431, King Abdullah Gardens Cross, Amman, JOR, 11184
The Consultant & Investment Group is a Jordan-based company that engages in the healthcare and medical sector. It is engaged in the provision of medical care services. The company generates revenue from medical services and the sale of medicine and medical/ supplies are recognized. The company gains majority of revenue from Jordan. The Group principally operates only in the Hashemite Kingdom of Jordan.
77GF Score

Get the complete analysis for AMM:CICO

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD1.78
Price
JOD2.20
GF Value